Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs MVA CMV (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions
- 31 Jul 2017 Status changed from active, no longer recruiting to completed.
- 28 Oct 2016 According to City of Hope and Helocyte media release, data from this study was published in Blood, the journal of the American Society of Hematology.
- 19 Oct 2016 Results published in the Blood